Polaris Market Research today announced findings from its latest report, projecting the global Near Infrared Imaging Market to grow from USD 2.32 billion in 2025 to USD 3.30 billion by 2034, at a CAGR of 4.02% from 2026 to 2034. The report profiles 13 leading companies across 3 market segments.

Near infrared (NIR) imaging is a noninvasive technique that captures light beyond the visible spectrum to penetrate deeper into tissue and produce high-contrast images without ionizing radiation. In medicine, it supports functional brain imaging, tumor detection, and blood-flow monitoring, and its non-destructive nature has also made it valuable in agriculture, food inspection, and art restoration.

Analyst Commentary on Near Infrared Imaging Market Growth

"Near infrared imaging is moving well beyond the operating room, from drug development to agricultural monitoring, and this market's growth reflects that expanding footprint." said a Research Director at Polaris Market Research. "Buyers should watch the devices segment and Asia Pacific region closely, since both are scaling faster than the market overall as AI-enhanced image processing matures."

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: the expanding geriatric population worldwide, which requires frequent, radiation-free diagnostic monitoring, increasing healthcare expenditure enabling hospitals to invest in advanced diagnostic and surgical technologies, and the rising prevalence of cardiovascular disease, which drives demand for noninvasive, real-time imaging are the primary forces behind the market's expansion, alongside growing demand for fluorescence-guided surgery. The World Health Organization reports that cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths each year, a burden that is pushing healthcare providers toward noninvasive imaging tools like NIR that can detect blockages and monitor blood flow in real time.

The aging population trend reinforces this further: the WHO projects the number of people aged 60 and above will grow from 1.1 billion in 2023 to 1.4 billion by 2030, and surgeons increasingly use NIR technology during procedures on elderly patients specifically because it carries no radiation exposure risk for repeated use. Restraint-side, high system cost and dependency on fluorescent dyes for many applications remain real barriers, particularly for smaller healthcare facilities and research organizations.

Major Companies Covered:

• FLUOPTICS SAS
• Hamamatsu Photonics K.K.
• Leica Microsystems
• LICORbio
• Medtronic (Visionsense)
• Mizuho Medical Co., Ltd.
• Olympus
• PerkinElmer
• Quest Diagnostics Incorporated
• Shimadzu Corporation
• Zeiss Group

Browse In-depth Market Research Report:

https://www.polarismarketresearch.com/industry-analysis/near-infrared-imaging-market 

Segments Covered: By Product (Devices, Reagents), By Indication (Preclinical Imaging, Cancer Surgeries, Gastrointestinal Surgeries, Cardiovascular Surgeries, Plastic/Reconstructive Surgeries), and By End Use (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Research Laboratories).

The product split is worth noting: reagents such as indocyanine green currently lead on revenue share given their central role in targeting biomarkers, while the devices segment, covering high-resolution cameras and handheld scanners, is projected to grow faster as adoption spreads across both clinical and preclinical settings.

Recent Developments in the Near Infrared Imaging Market

• April 2026: Remergify, Farrington Capital Group, and Near Infrared Imaging, LLC announced a strategic partnership integrating advanced NIR imaging hardware with proprietary AI to launch an AI-powered medical diagnostic suite.
• February 2025: Stryker completed its acquisition of Inari Medical, Inc., expanding into the high-growth peripheral vascular segment.

Regional Snapshot: North America Leads, Asia Pacific Fastest-Growing

North America led with 42.15% share in 2025, supported by growing advancements in medical diagnostics, strong healthcare infrastructure, and increasing adoption in surgeries, cancer detection, and ophthalmic diagnostics, while Asia Pacific is projected to register the fastest, at 5.1% growth through 2034 on the back of expanding healthcare infrastructure in China, Japan, and India, along with growing use of NIR in cancer detection and endoscopic procedures.

Within North America, the U.S. held 85% of the regional revenue share, driven by widespread use of NIR imaging in minimally invasive surgeries, brain imaging, and cardiovascular diagnostics, alongside growing use of the technology in food and agriculture quality control.

Why It Matters for Near infrared imaging market forecast

For stakeholders researching the near infrared imaging market forecast, the underlying report benchmarks Near Infrared Imaging Market share, company positioning, and segment-level forecasts to support sourcing, partnership, and investment decisions through 2034. The data is especially relevant for hospital and research procurement teams, since AI integration is increasingly the differentiator between NIR platforms, improving image clarity and enabling faster, more automated diagnostic interpretation.

Conclusion

In summary, near infrared imaging is moving from a specialized surgical tool toward a broader diagnostic and research staple, and the market's growth through 2034 reflects that expanding footprint. Buyers should watch the devices segment and Asia Pacific region closely, since both are scaling faster than the market overall.

More Trending Latest Reports By Polaris Market Research:

Quantum Dot Market

Precision Engineering Machines Market

Dental Consumables Market

An Overview of Minimal Residual Disease Market Growth and Trends

Lenalidomide Market

Lenalidomide Market

Dry Van Container Market

Smart Bathroom Market

Antiscalants Market